Cipla celebrates 90 years with focus on quality products, global presence, and investment in research and technology.

A significant reduction was not observed in the annualised rate of moderate or severe COPD exacerbations with tezepelumab versus placebo. Further studies are required to evaluate the efficacy of ...

Though long-term prospects appear sound, near-term earnings visibility remains limited for Dr. Reddy's Labs, Cipla, and Lupin ...